These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis.
    Author: Pandrangi S, Singh A, Wheeler DE, Rossi NF.
    Journal: Nat Clin Pract Nephrol; 2008 Jul; 4(7):393-7. PubMed ID: 18493239.
    Abstract:
    BACKGROUND: A 74-year-old woman with a history of type I cryoglobulinemia with glomerulonephritis that had been successfully treated with plasmapheresis and cyclophosphamide approximately 9 years earlier presented with hemoptysis and mediastinal lymphadenopathy. Evaluation revealed the reappearance of cryoglobulins and nephrotic-range proteinuria. In addition, the patient's serum creatinine level, which had been stable for approximately 9 years after her first treatment, had increased from 79.2 micromol/l (0.9 mg/dl) to 281.6 micromol/l (3.2 mg/dl) over 6 months. INVESTIGATIONS: Physical examination, serum and urine laboratory analyses, CT scan, mediastinoscopy with lymph node biopsy, bone marrow biopsy, flow cytometry analysis of bone marrow, peripheral blood and lymph node tissue, and percutaneous ultrasound-guided renal biopsy. DIAGNOSIS: Type I cryoglobulinemic glomerulonephritis associated with a CD20(+) lymphoid disorder. MANAGEMENT: One plasmapheresis treatment, one dose of cyclophosphamide, and four weekly cycles of rituximab.
    [Abstract] [Full Text] [Related] [New Search]